000 01650 a2200517 4500
005 20250513110445.0
264 0 _c19970130
008 199701s 0 0 eng d
022 _a0007-1048
024 7 _a10.1046/j.1365-2141.1996.d01-1943.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMathiot, C
245 0 0 _aSoluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS).
_h[electronic resource]
260 _bBritish journal of haematology
_cDec 1996
300 _a660-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers
650 0 4 _aDisease Progression
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xdiagnosis
650 0 4 _aParaproteinemias
_xdiagnosis
650 0 4 _aPrognosis
650 0 4 _aReceptors, IgG
_xblood
650 0 4 _aSensitivity and Specificity
700 1 _aMary, J Y
700 1 _aTartour, E
700 1 _aFacon, T
700 1 _aMonconduit, M
700 1 _aGrosbois, B
700 1 _aPollet, J P
700 1 _aMichaux, J L
700 1 _aEuller Ziegler, L
700 1 _aSautès, C
700 1 _aBataille, R
700 1 _aFridman, W H
773 0 _tBritish journal of haematology
_gvol. 95
_gno. 4
_gp. 660-5
856 4 0 _uhttps://doi.org/10.1046/j.1365-2141.1996.d01-1943.x
_zAvailable from publisher's website
999 _c8973519
_d8973519